Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells

Bone

Volumn 39, Issue 2, 2006, Pages 283-288

  Maddi, Abhiram ^a,b   Hai, HoKee ^b   Ong, Siew Tin ^c   Sharp, Lindsay ^a   Harris, Malcolm ^a,d   Meghji, Sajeda ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Long wave ultrasound; OPG; Osteoblasts; RANKL

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; BONE REGENERATION; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROENVIRONMENT; OSTEOBLAST; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; ULTRASOUND;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REGENERATION; CARRIER PROTEINS; CELL LINE; CULTURE MEDIA; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; OSTEOBLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TIME FACTORS; ULTRASONICS;

EID: 33744904453     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.01.162     Document Type: Article

References (38)

1. Teitelbaum S.L., Tondravi M.M., and Ross F.P. Osteoclasts, macrophages and the molecular mechanism of bone resorption. J. Leuk. Biol. 61 (1997) 381-388
2. Tat S., Padrines M., Theoleyre S., Heymann D., and Fortun Y. IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathology. Cytokine Growth Factor Rev. 15 (2004) 49-60
3. Hofbauer L.C., and Heufelder. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J. Clin. Endocrinol. Metab. 85 (2000) 2355-2363
4. Hsu H., Lacey D.L., Dunstan C.R., Solovyev I., Colombero A., Timms E., et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3540-3545
5. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Goto M., et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25 (1999) 109-113
6. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3597-3602
7. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 39 (1998) 1329-1337
8. Thomson B.M., Mundy G.R., and Chambers T.J. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138 3 (1987 (Feb. 1)) 775-779
9. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., and Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 15 1 (2000 (Jan.)) 2-12
10. Fuller K., Murphy C., Kirstein B., Fox S.W., and Chambers T.J. TNF alpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143 3 (2002 (Mar)) 1108-1118
11. 3H] urinary tetracycline excretion from prelabeled mice. J. Bone Miner. Res. 3 (1988) 621-627
12. Dyson M., Pond J.B., Joseph J., and Warwick R. The stimulation of tissue regeneration by means of ultrasound. Clin. Sci. 35 (1968) 273-285
13. Dyson M., Franks C., and Suckling J. Stimulation of healing of varicose ulcers by ultrasound. Ultrasonics 14 (1976) 232-236
14. Harvey W., Dyson M., Pond J.B., and Grahame R. The stimulation of protein synthesis in human fibroblasts by therapeutic ultrasound. Rheumatol. Rehab. 14 (1975) 237
15. Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br. J. Oral Maxillofac. Surg. 30 (1992) 313
16. Doan N., Reher P., Meghji S., and Harris M. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis and cytokine production by human fibroblasts, osteoblasts and monocytes. J. Oral Maxillofac. Surg. 57 4 (1999) 409-419
17. Yang K.H., Parvizi J., Wang S.J., Lewallen D.G., Kinnick R.R., Greenleaf J.F., et al. Exposure to low-intensity ultrasound increases aggrecan gene expression in a rat femur fracture model. J. Orthop. Res. 14 5 (1996 (Sep.)) 802-809
18. Dyson M., and Brookes M. Stimulation of bone repair by ultrasound. Ultrasound Med. Biol. 9 (1983) 50
19. Pilla A.A., Mont M.A., Nasser P.R., et al. Non-invasive low intensity pulsed ultrasound accelerates bone healing in the rabbit. J. Orthop. Trauma 4 (1990) 246-253
20. Tsai C.L., Chang W.H., and Liu T.K. Preliminary studies of duration and intensity of ultrasonic treatments on fracture repair. Chin. J. Physiol. 35 1 (1992) 21-26
21. Reher P., Doan N., Bradnock B., Meghji S., and Harris M. Effect of ultrasound on the production of IL-8, basic FGF and VEGF. Cytokine 11 6 (1999 (Jun.)) 416-423
22. Jacobson A., Johansson S., Branting M., and Melhus H. Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. Biochem. Biophys. Res. Commun. 322 1 (2004 (Sep. 10)) 162-167
23. Bu R., Borysenko C.W., Li Y., Cao L., Sabokbar A., and Blair H.C. Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone 33 5 (2003 (Nov)) 760-770
24. Heckman J.D., Ryaby J.P., McCabe J., Frey J.J., and Kilcoyne R.F. Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J. Bone Jt. Surg. Am. 76 1 (1994 (Jan.)) 26-34
25. Sakarakuchi K., Tsuchiya H., Uehara K., Yamashiro T., Tomita K., and Azuma Y. Effects of timing of low-intensity pulsed ultrasound on distraction osteogenesis. J. Orthop. Res. 22 2 (2004 (Mar.)) 395-403
26. Sandberg M.M., Aro H.T., and Vuorio E.I. Gene expression during bone repair. Clin. Orthop. 289 (1993 (Apr.)) 292-312
27. Salter D.M., Wallace W.H., Robb J.E., Caldwell H., and Wright M.O. Human bone cell hyperpolarization response to cyclical mechanical strain is mediated by an interleukin-1beta autocrine/paracrine loop. J. Bone Miner. Res. 15 9 (2000 (Sep.)) 1746-1755
28. Reher P., Harris M., Whiteman M., Hai H.K., and Meghji S. Ultrasound stimulates nitric oxide and prostaglandin E2 production by human osteoblasts. Bone 31 1 (2002 (Jul.)) 236-241
29. Warden S.J., Bennell K.L., Matthews B., Brown D.J., McMeeken J.M., and Wark J.D. Efficacy of low-intensity pulsed ultrasound in the prevention of osteoporosis following spinal cord injury. Bone 29 5 (2001 (Nov.)) 431-436
30. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclasts differentiation and activation. Cell 93 2 (1998 (Apr. 17)) 165-176
31. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 6717 (1999 (Jan. 28)) 315-323
32. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 2 (1997 (Apr. 18)) 309-319
33. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12 9 (1998 (May 1)) 1260-1268
34. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 247 3 (1998 (Jun. 29)) 610-615
35. Udagawa N., Takahashi N., Yasuda H., Mizuno A., Itoh K., Ueno Y., et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141 9 (2000 (Sep.)) 3478-3484
36. Gori F., Hofbauer L.C., Dunstan C.R., Spelsberg T.C., Khosla S., and Riggs B.L. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells are developmentally regulated. Endocrinology 141 12 (2000 (Dec.)) 4768-4776
37. Clover J., and Gowen M. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype?. Bone 15 6 (1994 (Nov.-Dec.)) 585-591
38. Malaval L., Modrowski D., Gupta A.K., and Aubin J.E. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J. Cell Physiol. 158 3 (1994 (Mar.)) 555-572